Abstract
Introduction
Onyx has emerged in the recent years as a new embolic material. We present our experience with Onyx in the curative embolization of brain cerebral arteriovenous malformations (AVMs).
Methods
We retrospectively reviewed the files of all patients that we had treated with Onyx embolic material for a brain AVM during the last 4 years. We identified 101 patients who underwent a total of 219 sessions of embolization.
Results
The treatment has been concluded in 52 patients; in this group, total occlusion was obtained in 28 (53.9%) patients and near-total occlusion was obtained in 18 (34.6%). The respective figures based on the 101 patients of the study cohort are 28/101 (27.7%) and 18/101 (17.8%). More embolization sessions are to be carried out on the remaining 49 patients. There were three deaths, and eight patients had permanent neurological deficits with a resulting morbidity of 8% and mortality of 3%.
Conclusion
High rates of total or near-total occlusion of brain AVMs can be achieved with multiple sessions of Onyx embolization with acceptable morbidity and mortality
Similar content being viewed by others
References
Brothers MF, Kaufmann JC, Fox AJ et al. (1989) n-Butyl 2-cyanoacrylate-substitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies. AJNR Am J Neuroradiol 10:777–786
Yamashita K, Taki W, Iwata H et al. (1994) Characteristics of ethylene vinyl alcohol copolymer (EVAL) mixtures. AJNR Am J Neuroradiol 15:1103–1105
Henkes H, Nahser HC, Berg-Dammer E et al. (1998) Endovascular therapy of brain AVMs prior to radiosurgery. Neurol Res 20:479–492
Jafar JJ, Davis AJ, Berenstein A et al. (1993) The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations. J Neurosurg 78:60–69
Murayama Y, Vinuela F, Ulhoa A et al. (1998) Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurgery 43:1164–1175
Paulsen RD, Steinberg GK, Norbash AM et al. (1999) Embolization of rolandic cortex arteriovenous malformations. Neurosurgery 44:479–484
Jahan R, Murayama Y, Gobin YP et al. (2001) Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery 48:984–995
n-BCA Trail Investigators (2002) n-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial. AJNR Am J Neuroradiol 23:748–755
Taylor CL, Dutton K, Rappard G et al. (2004) Complications of preoperative embolization of cerebral arteriovenous malformations. J Neurosurg 100:810–812
Weber W, Kis B, Siekman R, Kuehne D (2007) Endovascular treatment of intracranial arteriovenous malformations with Onyx: Technical aspects. AJNR Am J Neuroradiol 28:371–377
van Rooij WJ, Sluzewski M, Beute GN (2007) Brain AVM Embolization with Onyx. AJNR Am J Neuroradiol 28:172–177
Mounayer C, Hammami N, Piotin M et al. (2007) Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol 28:518–523
Chyatte D (1997) Normal pressure perfusion breakthrough after resection of arteriovenous malformation. J Stroke Cerebrovasc Dis 6:130–136
Kato Y, Sano H, Nonomura K et al. (1997) Normal perfusion pressure breakthrough syndrome in giant arteriovenous malformations. Neurol Res 19:117–123
Day AL, Friedman WA, Sypert GW, Mickle JP (1982) Successful treatment of the normal perfusion pressure breakthrough syndrome. Neurosurgery 11:625–630
Debrun GM, Aletich V, Ausman JI et al. (1997) Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery 40:112–120
Fournier D, TerBrugge KG, Willinsky R et al. (1991) Endovascular treatment of intracerebral arteriovenous malformations: experience in 49 cases. J Neurosurg 75:228–233
Deruty R, Pelissou-Guyotat I, Mottolese C et al. (1993) The combined management of cerebral arteriovenous malformations. Experience with 100 cases and review of the literature. Acta Neurochir (Vienna) 123:101–112
Wilms G, Goffin J, Plets C et al (1993) Embolization of arteriovenous malformations of the brain: preliminary experience. J Belge Radiol 76:299–303
Liu HM, Huang YC, Wang YH (2000) Embolization of cerebral arteriovenous malformations with n-butyl-cyanoacrylate. J Formos Med Assoc 99:906–913
Meisel HJ, Mansmann U, Alvarez H et al. (2002) Effect of partial targeted N-butyl-cyano-acrylate embolization in brain AVM. Acta Neurochir (Vienna) 144:879–887
Wikholm G, Lundquist C, Svendsen P (2001) The Goteborg cohort of embolized cerebral arteriovenous malformations: a 6-year follow-up. Neurosurgery 49:799–805
Cronquist M, Wirestam R, Ramgren B et al. (2006) Endovascular treatment of intracerebral arteriovenous malformations: procedural safety, complications and results evaluated by MR imaging, including diffusion and perfusion imaging. AJNR Am J Neuroradiol 27:162–176
Haw CS, terBrugge K, Wllinsky R, Tomlinson G (2006) Complications of embolization of arteriovenous malformations of the brain. J Neurosurg 104:226–232
DeMeritt JS, Pile-Spellman J, Mast H (1995) Outcome analysis of preoperative embolization with n-butyl cyanoacrylate in cerebral arteriovenous malformations. AJNR Am J Neuroradiol 16:1801–1807
Frizzel RT, Fisher WS 3rd (1995) Cure, morbidity and mortality associated with embolization of brain arteriovenous malformations: a review of 1246 patients in 32 series over a 35-year period. Neurosurgery 37:1039–1040
Valavanis A, Yasargil MG (1998) The endovascular treatment of brain arteriovenous malformations. Adv Tech Stand Neurosurg 24:131–140
Conflict of interest statement
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Katsaridis, V., Papagiannaki, C. & Aimar, E. Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology 50, 589–597 (2008). https://doi.org/10.1007/s00234-008-0382-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-008-0382-x